The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Kelsey's Stock Ratings
HC Wainwright & Co. Analyst
Matthew Kelsey is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025
Overall Average Return
-34.9%
Smart Score
Overall Average Return Percentile
6th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/15/2025 | ACXP | Buy Now | Acurx Pharmaceuticals | $0.39 | 1967.72% | Matthew Kelsey21% | → $8 | Assumes | → Buy | Get Alert |
| 12/20/2018 | DBVT | Buy Now | DBV Technologies | $10.63 | -5.93% | Matthew Kelsey21% | $26 → $10 | Maintains | Equal-Weight | Get Alert |
| 09/11/2018 | DBVT | Buy Now | DBV Technologies | $10.63 | 154% | Matthew Kelsey21% | $28 → $27 | Maintains | Equal-Weight | Get Alert |
| 07/13/2018 | DBVT | Buy Now | DBV Technologies | $10.63 | 163.41% | Matthew Kelsey21% | $27 → $28 | Maintains | Equal-Weight | Get Alert |
| 10/06/2017 | DBVT | Buy Now | DBV Technologies | $10.63 | 577.33% | Matthew Kelsey21% | $70 → $72 | Maintains | Overweight | Get Alert |
| 07/10/2017 | DBVT | Buy Now | DBV Technologies | $10.63 | 530.29% | Matthew Kelsey21% | $65 → $67 | Maintains | Overweight | Get Alert |
